Literature DB >> 16757166

beta-Secretase inhibitors: modification at the P4 position and improvement of inhibitory activity in cultured cells.

Yoshio Hamada1, Naoto Igawa, Hayato Ikari, Zyta Ziora, Jeffrey-Tri Nguyen, Abdellah Yamani, Koushi Hidaka, Tooru Kimura, Kazuki Saito, Yoshio Hayashi, Maiko Ebina, Shoichi Ishiura, Yoshiaki Kiso.   

Abstract

Recently, we reported potent and small-sized beta-secretase (BACE1) inhibitors KMI-570 and KMI-684 in which we replaced carboxylic acid groups at the P(1)(') position of KMI-420 and KMI-429, respectively, with tetrazole derivatives as carboxylic acid bioisosteres. These modifications improved significantly BACE1 inhibitory activity and chemical stability. In this study, the acidic tetrazole ring of the P(4) position of KMI-420 and KMI-570, respectively, was replaced with various hydrogen bond acceptor groups. We found BACE1 inhibitor KMI-574 that exhibited potent inhibitory activity in cultured cells as well as in vitro enzymatic assay.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16757166     DOI: 10.1016/j.bmcl.2006.05.046

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  6 in total

1.  BACE1 Inhibitor Peptides: Can an Infinitely Small k cat Value Turn the Substrate of an Enzyme into Its Inhibitor?

Authors:  Yoshio Hamada; Shoichi Ishiura; Yoshiaki Kiso
Journal:  ACS Med Chem Lett       Date:  2011-12-26       Impact factor: 4.345

Review 2.  beta-Secretase as a therapeutic target for Alzheimer's disease.

Authors:  Arun K Ghosh; Sandra Gemma; Jordan Tang
Journal:  Neurotherapeutics       Date:  2008-07       Impact factor: 7.620

Review 3.  The structural evolution of β-secretase inhibitors: a focus on the development of small-molecule inhibitors.

Authors:  Stefania Butini; Simone Brogi; Ettore Novellino; Giuseppe Campiani; Arun K Ghosh; Margherita Brindisi; Sandra Gemma
Journal:  Curr Top Med Chem       Date:  2013       Impact factor: 3.295

Review 4.  BACE1 (β-secretase) inhibitors for the treatment of Alzheimer's disease.

Authors:  Arun K Ghosh; Heather L Osswald
Journal:  Chem Soc Rev       Date:  2014-10-07       Impact factor: 54.564

Review 5.  Amylin and Secretases in the Pathology and Treatment of Alzheimer's Disease.

Authors:  Som Singh; Felix Yang; Andy Sivils; Victoria Cegielski; Xiang-Ping Chu
Journal:  Biomolecules       Date:  2022-07-17

Review 6.  New directions for protease inhibitors directed drug discovery.

Authors:  Yoshio Hamada; Yoshiaki Kiso
Journal:  Biopolymers       Date:  2016-11-04       Impact factor: 2.505

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.